Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Jubilant Pharmova Limited ( (IN:JUBLPHARMA) ) has issued an announcement.
Jubilant Pharmova Limited has launched the ‘Saksham Niveshak’ campaign, a 100-day initiative aimed at reminding shareholders about unpaid or unclaimed dividends. This campaign signifies the company’s proactive approach in engaging with its shareholders and ensuring that they receive their due entitlements, potentially strengthening shareholder relations and trust.
More about Jubilant Pharmova Limited
Jubilant Pharmova Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of a wide range of pharmaceutical products and services. The company is known for its contributions to healthcare and pharmaceuticals, aiming to address various medical needs and enhance patient care.
Average Trading Volume: 8,555
Technical Sentiment Signal: Buy
Current Market Cap: 185B INR
For a thorough assessment of JUBLPHARMA stock, go to TipRanks’ Stock Analysis page.